Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-catabolising enzyme inducing immune tolerance. The present study aimed to investigate IDO expression and its prognostic significance in endometrial cancer. Indoleamine 2,3-dioxygenase expression in endometrial cancer tissues (n=80) was immunohistoche...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ino, K, Yoshida, N, Kajiyama, H, Shibata, K, Yamamoto, E, Kidokoro, K, Takahashi, N, Terauchi, M, Nawa, A, Nomura, S, Nagasaka, T, Takikawa, O, Kikkawa, F
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2006
Gaiak:
Molecular Diagnostics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360726/
https://ncbi.nlm.nih.gov/pubmed/17117179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603477
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak